An integrated team of UCSF researchers and physicians in fields of cell development, metabolism, and immunology
...a history of innovation, a vision of a cure
Jeff Bluestone has spent nearly four decades advancing our understanding of the immune system and immune tolerance, helping turn fundamental discoveries into new treatments for autoimmune disease, including the first FDA-approved treatment to delay the onset of type 1 diabetes.
New paper out of @Tang_Lab_UCSF "Receptor-tethered orthogonal IL-2 enhances regulatory T cell therapy" features video from co-first authors
doi.org/10.1084/jem.20251480
UCSF Endocrinology & Metabolism which include many Diabetes Center members are vastly represented at #ENDO2026 with over 50 sessions, plenaries, symposia, talks, and posters:
diabetes.ucsf.edu/Endo2026
Congratulations to Nutrition and Obesity Research Center @NorcUcsf Associate Director Elissa Epel, PhD @Dr_Epel for her election to the American Association for the Advancement of Science @aaas
Congratulations to @Tang_Lab_UCSF postdoc @RobertoCG96, recipient of a @BreakthroughT1D 2026 advanced postdoctoral fellowship for "Engineering Treg Signaling to Develop an Effective Cell Therapy for Type 1 Diabetes"
Congrats to the 2026 Diabetes Center Fellows. We thank the Kraft and Klein families for their ongoing generous support. This year marks the inaugural launch of the Bluestone Family fellowship, supported by and named after our founding director.
Having a great time at the 2025 Obesity, Metabolism & Diabetes Research Retreat in partnership with UCSF Diabetes Center, UCSF Nutrition Obesity Research Center (NORC), @UCBerkeley Metabolic Biology, and
@ucdavis College of Biological Sciences